Opdivo (nivolumab)

pCPA File Number: 20880
Negotiation Status:
Concluded with an LOI
Indication(s):
Non-small Cell Lung Cancer
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CADTH Project Number:
pCODR 10069
pCPA Engagement Letter Issued:
Negotiation Process Concluded: